Related Experiment Video
Updated: Sep 20, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes
Mostafa Safi1, Anna Borup1, Christian Stevns Hansen2
1Department of Clinical Biochemistry, Rigshospitalet, Denmark; Department of Biomedical Sciences, University of Copenhagen, Denmark.
Insights
Increased plasma apolipoprotein M (apoM) is linked to a higher risk of cardiac autonomic neuropathy (CAN) in individuals with Type 1 Diabetes. This finding suggests potential changes in the autonomic nervous system
Area of Science:
- Cardiovascular Research
- Metabolic Disorders
- Autonomic Nervous System Function
Background:
- Diabetes mellitus can lead to serious complications like cardiac autonomic neuropathy (CAN), increasing cardiovascular mortality risk.
- Cardiac autonomic neuropathy (CAN) is diagnosed by reduced heart rate variability (HRV).
- HDL-associated apolipoprotein M (apoM) influences heart rate and HRV, with S1P agonists showing potential therapeutic benefits.
Purpose of the Study:
- To investigate the association between plasma levels of apolipoprotein M (apoM) and the risk of developing cardiac autonomic neuropathy (CAN).
- To explore the relationship between apoM and heart rate variability (HRV) indices in individuals with Type 1 Diabetes.
Main Methods:
- The study included 278 individuals diagnosed with Type 1 Diabetes.
- Data was collected from participants recruited at Steno Diabetes Center in Copenhagen between 2010 and 2012.
- Plasma apoM levels were measured and analyzed for association with CAN diagnosis and HRV parameters.
Main Results:
- Elevated plasma apoM levels were significantly associated with an increased risk of CAN.
- A 0.1 µM increase in plasma apoM correlated with CAN diagnosis (OR: 1.11, p=0.013).
- Plasma apoM was also linked to reduced HRV indices, including SDNN and high-frequency power, even after adjusting for various clinical factors.
Conclusions:
- Increased plasma apoM is associated with a higher risk of cardiac autonomic neuropathy (CAN) in Type 1 Diabetes patients.
- The observed association suggests potential alterations in parasympathetic activity.
- Further research is warranted to elucidate the underlying molecular mechanisms and explore additional contributing factors.
Aim:
Diabetes may lead to severe complications e.g. cardiac autonomic neuropathy (CAN) characterized by an increased risk of cardiovascular mortality. CAN is diagnosed by a decreased heart rate viability (HRV). Sphingosine-1-Phosphate (S1P) carried by the HDL-associated apolipoprotein M (apoM) is linked to a reduction in the heart rate, and treatment with an S1P-agonist increases HRV. The present study aimed to investigate if plasma apoM was associated with an increased risk of CAN.
Methods:
The study includes 278 individuals with Type 1 Diabetes recruited from Steno Diabetes Center in Copenhagen from 2010 to 2012.
Results:
A change of 0.1 µM plasma apoM was associated with the diagnosis of CAN (Odds ratio: 1.11 (1.02; 1.21), p = 0.013). ApoM plasma levels were also positively associated with CAN when adjusted for age and gender (Odds ratio: 1.11 (1.02; 1.21), p = 0.013) as well as lipids, beta-blockers, blood pressure, and alcohol (Odds ratio: 1.14 (1.04; 1.26), p = 0.005) and Hbga1c and time with diabetes (Odds ratio: 1.13 (1.02; 1.25), p = 0.01). Plasma apoM was also associated with a significantly lower SDNN as well as high frequency power in all adjusted models.
Conclusion:
Increased plasma apoM was associated with an increased risk of CAN as well as a significant reduction in HRV indices. This could represent changes in parasympathetic activity, but, further studies are needed to also explore additional molecular alterations behind such observations.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Peripheral Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational

